# SULINDAC

NDC: 0904-7334
Generic name: sulindac
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230727
Marketing ended: 20260731
FDA application: ANDA072050

## Active ingredients

- SULINDAC: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7334"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7334
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41c7882e-530a-4ac1-8de4-8d1e7b391467